Related Experiment Video
Updated: Dec 21, 2025

Applying an Inducible Expression System to Study Interference of Bacterial Virulence Factors with Intracellular Signaling
Published on: June 25, 2015
Septin4 promotes cell death in human colon cancer cells by interacting with BAX
Xin Zhao1, Hao Feng2, Yang Wang3
1Key Laboratory of Medical Cell Biology, Ministry of Education; Institute of Translational Medicine, Collegeof Medical Science, China Medical University; Liaoning Province, Collaborative Innovation Center of Aging Related Disease Diagnosis and Treatment and Prevention, Shenyang, Liaoning Province, China.
Abstract:
Septin4 is a tumor suppressor protein that promotes cell programmed death in various cell types through specifically antagonizing XIAP (X linked inhibitor of apoptosis), little is known its other novel binding partner and role in colorectal cancer. In this study, we found that Septin4 significantly expressed lower in human colon cancer when compared to peri-tumor benign cells, and its low expression was significantly associated with worse prognostic outcomes. Furthermore, Septin4 participated in DOX-induced colon cancer cell death in vitro. Septin4-overexpressing colon cancer cells displayed augmented apoptotic cell death and ROS production. Additionally, Septin4-knockdown cells revealed a resistance of DOX-induced cell death and reduced ROS production. Importantly, we first identified that BAX is a novel Septin4 binding partner and the interaction is enhanced under DOX treatment. Finally, Septin4-knockdown promoted colon cells growth in vivo. These observations suggest that Septin4 as an essential molecule contribute to the occurrence and development of human colon cancer and provide new technical approaches for targeted treatment of this disease.
Insights
Septin4, a tumor suppressor, is downregulated in colorectal cancer, promoting cell death and worsening prognosis. It interacts with BAX, enhancing Doxorubicin-induced cell death and ROS production.
Area of Science:
- Oncology
- Molecular Biology
- Cell Biology
Background:
- Septin4 acts as a tumor suppressor by promoting apoptosis via XIAP antagonism.
- Its role and binding partners in colorectal cancer (CRC) remain largely unexplored.
Purpose of the Study:
- To investigate the role of Septin4 in colorectal cancer development and its interaction with BAX.
- To explore Septin4's potential as a therapeutic target in CRC.
Main Methods:
- Quantitative analysis of Septin4 expression in human colon cancer tissues.
- In vitro studies using Septin4-overexpressing and knockdown colon cancer cell lines.
- In vivo studies to assess Septin4's effect on tumor growth.
Main Results:
- Septin4 expression is significantly lower in colon tumors than adjacent normal tissue, correlating with poor prognosis.
- Septin4 overexpression enhances Doxorubicin (DOX)-induced apoptosis and ROS production.
- Septin4 knockdown confers resistance to DOX-induced cell death and reduces ROS levels.
- BAX identified as a novel Septin4 binding partner, with interaction enhanced by DOX.
- Septin4 knockdown promotes colon cancer cell growth in vivo.
Conclusions:
- Septin4 functions as a crucial tumor suppressor in colorectal cancer.
- Septin4's interaction with BAX is vital for DOX-induced apoptosis.
- Septin4 represents a promising target for novel colorectal cancer therapies.
More Related Videos
19:44Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen
Published on: May 30, 2012
15:53Cell Death Associated with Abnormal Mitosis Observed by Confocal Imaging in Live Cancer Cells
Published on: August 21, 2013
Related Concept Videos
The Intrinsic Apoptotic Pathway
The Extrinsic Apoptotic Pathway
Role of Septins
Cellular Functions of Septins
Recent studies have revealed the multifaceted roles of septins in various cellular processes such as cytokinesis, ciliogenesis, and neurogenesis. Septins act as scaffolds and...
Caspases
Septins
Apoptosis